Regulatory bodies and health care systems should systematically evaluate the safety and cost-effectiveness of new cardiovascular treatments in health care registries using prospectively designed protocols

MeSH terms

• Cardiovascular Diseases* / diagnosis
• Cardiovascular Diseases* / economics
• Cardiovascular Diseases* / therapy
• Cost-Benefit Analysis*
• Health Care Costs / legislation & jurisprudence
• Humans
• Patient Safety
• Prospective Studies
• Registries*
• Treatment Outcome